Skip to content

Clinical trials

Phase 2 Anemia, Sickle Cell trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 2 Country / region: France Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20132
20151
20171
20181
20192
20211
20223
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
Novartis Pharmaceuticals3
Theravia3
Agios Pharmaceuticals, Inc.1
AstraZeneca1
CSL Behring1
Centre Hospitalier Intercommunal Creteil1
Forma Therapeutics, Inc.1
Hoffmann-La Roche1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell18
Albuminuria2
Anemia2
Vaso-Occlusive Crises2
Acute Chest Syndrome1
COVID-191
Genetic Diseases, Inborn1
Hemoglobin SC Disease1
Hemolysis1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.